BioCentury
ARTICLE | Company News

Bausch + Lomb, Paragon BioTeck Inc. sales and marketing update

April 29, 2013 7:00 AM UTC

Bausch + Lomb received exclusive U.S. commercialization rights to Paragon's phenylephrine hydrochloride solution. FDA approved the adrenergic receptor alpha 1 (ADRA1) agonist for pupil dilation last ...